These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30231890)

  • 1. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone.
    Engellau J; Seeger L; Grimer R; Henshaw R; Gelderblom H; Choy E; Chawla S; Reichardt P; O'Neal M; Feng A; Jacobs I; Roberts ZJ; Braun A; Bach BA
    World J Surg Oncol; 2018 Sep; 16(1):191. PubMed ID: 30231890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T; Morioka H; Nishida Y; Kakunaga S; Tsuchiya H; Matsumoto Y; Asami Y; Inoue T; Yoneda T
    Ann Oncol; 2015 Oct; 26(10):2149-54. PubMed ID: 26205395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
    Chawla S; Henshaw R; Seeger L; Choy E; Blay JY; Ferrari S; Kroep J; Grimer R; Reichardt P; Rutkowski P; Schuetze S; Skubitz K; Staddon A; Thomas D; Qian Y; Jacobs I
    Lancet Oncol; 2013 Aug; 14(9):901-8. PubMed ID: 23867211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
    Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
    Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
    Arefpour A; Shafieesabet M; Chehrassan M; Ahmadzadehnanva A; Ghandhari H
    Musculoskelet Surg; 2024 Mar; 108(1):93-98. PubMed ID: 37940782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E; Chawla NS; Ferrari S; Sudan M; Picci P; Marchesi E; Leopardi MP; Syed I; Sankhala KK; Parthasarathy P; Mendanha WE; Pierini M; Paioli A; Chawla SP
    Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
    Palmerini E; Seeger LL; Gambarotti M; Righi A; Reichardt P; Bukata S; Blay JY; Dai T; Jandial D; Picci P
    BMC Cancer; 2021 Jan; 21(1):89. PubMed ID: 33482769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
    Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D; A Taguibao R; A Strle N; E Burns J
    Skeletal Radiol; 2017 Apr; 46(4):571-578. PubMed ID: 28188337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological findings of denosumab treatment for giant cell tumours of bone.
    van Langevelde K; McCarthy CL
    Skeletal Radiol; 2020 Sep; 49(9):1345-1358. PubMed ID: 32335707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J; Lee YH; Kim SK; Kim SH; Song HT; Shin KH; Suh JS
    J Orthop Sci; 2018 May; 23(3):570-577. PubMed ID: 29429890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
    Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
    Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL; Hansen RL; Jørgensen PH
    Ugeskr Laeger; 2016 Sep; 178(36):. PubMed ID: 27593237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.
    Boye K; Jebsen NL; Zaikova O; Knobel H; Løndalen AM; Trovik CS; Monge OR; Hall KS
    Acta Oncol; 2017 Mar; 56(3):479-483. PubMed ID: 28105885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
    Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
    Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
    Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.